7Baggers
 Coherus BioSciences stock stays supported by oncology focus  AD HOC NEWS Thu, 09 Jul 2026 18:29:38 GMT
 Coherus and Zumutor Biologics Announce Clinical  GlobeNewswire Tue, 23 Jun 2026 18:00:40 GMT
 Coherus and Zumutor announce phase 1 cancer trial collaboration  Investing.com Tue, 23 Jun 2026 07:00:00 GMT
 coherus biosciences inc (chrs) institutional confidence  TradingKey Wed, 17 Jun 2026 14:15:14 GMT
 Coherus Oncology appoints PwC as new auditor, replaces Ernst & Young  Investing.com Mon, 15 Jun 2026 07:00:00 GMT
 coherus biosciences announces 2026 stockholder meeting results  The Globe and Mail Tue, 02 Jun 2026 13:28:00 GMT
 chrs - coherus oncology inc stock price and quote  Finviz Tue, 26 May 2026 23:59:07 GMT
 coherus biosciences signals momentum in earnings call  TipRanks Wed, 20 May 2026 01:20:46 GMT
 coherus biosciences signals confident oncology earnings outlook  TipRanks Wed, 13 May 2026 00:19:09 GMT
 coherus oncology q1 2026 earnings call transcript  MarketBeat Tue, 12 May 2026 09:33:57 GMT
 coherus biosciences signals confident oncology earnings outlook  TipRanks Tue, 12 May 2026 07:00:00 GMT
 tradingkey  TradingKey Tue, 12 May 2026 02:26:00 GMT
 coherus (chrs) reports q1 revenue below expectations  GuruFocus Tue, 12 May 2026 01:12:42 GMT
 coherus oncology : chrs  24/7 Wall St. Mon, 11 May 2026 12:01:36 GMT
 Coherus BioSciences earnings matched, revenue fell short of estimates  Investing.com Mon, 11 May 2026 07:00:00 GMT
 cancer drug maker posts $11.8m from loqtorzi amid $36.9m q1 loss  Stock Titan Mon, 11 May 2026 07:00:00 GMT
 coherus (chrs) reports q1 revenue below expectations  GuruFocus Mon, 11 May 2026 07:00:00 GMT
 coherus biosciences ($chrs) releases q1 2026 earnings  Quiver Quantitative Mon, 11 May 2026 07:00:00 GMT
 coherus oncology reports q1 eps (28c), consensus (26c)  TipRanks Mon, 11 May 2026 07:00:00 GMT
 guggenheim starts coherus with buy on anti-tumor potential  TipRanks Mon, 11 May 2026 07:00:00 GMT
 u.s. fda declines to approve two more china-tested drugs  The Standard (HK) Mon, 27 Apr 2026 19:12:10 GMT
 coherus oncology prices stock offering to raise $50.1m  MSN Thu, 23 Apr 2026 15:27:08 GMT
 wall street analysts are bullish on top healthcare picks  The Globe and Mail Sat, 11 Apr 2026 07:00:00 GMT
 coherus biosciences charts leaner path after earnings call  TipRanks Fri, 10 Apr 2026 11:57:43 GMT
 coherus biosciences stock: biosimilar bets amid biotech volatility  AD HOC NEWS Wed, 08 Apr 2026 16:11:59 GMT
 published on: 2026-04-08 21:24:41  baoquankhu1.vn Tue, 07 Apr 2026 14:16:12 GMT
 coherus biosciences charts leaner path after earnings call  TipRanks Fri, 03 Apr 2026 00:18:50 GMT
 coherus biosciences charts leaner path after earnings call  TipRanks Thu, 02 Apr 2026 07:00:00 GMT
 published on: 2026-03-27 06:49:07  baoquankhu1.vn Thu, 26 Mar 2026 23:49:07 GMT
 coherus oncology (chrs) upgraded to buy: here's what you should know  Yahoo Finance Wed, 25 Mar 2026 07:00:00 GMT
 metastatic hepatocellular carcinoma clinical trial pipeline  openPR.com Wed, 25 Mar 2026 07:00:00 GMT
 published on: 2026-03-19 04:27:14  baoquankhu1.vn Wed, 18 Mar 2026 21:28:17 GMT
 coherus biosciences q4 2025 earnings preview  MSN Sun, 15 Mar 2026 14:48:07 GMT
 coherus biosciences q4 2025 earnings preview  MSN Tue, 10 Mar 2026 07:06:19 GMT
 oppenheimer reiterates coherus biosciences stock rating at outperform  Investing.com Tue, 10 Mar 2026 07:00:00 GMT
 coherus oncology q4 2025 earnings call transcript  MarketBeat Tue, 10 Mar 2026 03:52:01 GMT
 coherus oncology reports q4 eps (34c), consensus (31c)  TipRanks Tue, 10 Mar 2026 03:40:38 GMT
 coherus oncology reports q4 eps (34c), consensus (31c)  TipRanks Mon, 09 Mar 2026 23:19:05 GMT
 COHERUS BIOSCIENCES ($CHRS) Releases Q4 2025 Earnings  Quiver Quantitative Mon, 09 Mar 2026 07:00:00 GMT
 cancer drug loqtorzi sales double to $40.8m as trials near  Stock Titan Mon, 09 Mar 2026 07:00:00 GMT
 coherus oncology (chrs) reports q4 loss, misses revenue estimates  Yahoo Finance Mon, 09 Mar 2026 07:00:00 GMT
 coherus biosciences earnings matched, revenue fell short of estimates  Investing.com Mon, 09 Mar 2026 07:00:00 GMT
 chrs q4 revenue falls short but strategic shift shows promise  GuruFocus Mon, 09 Mar 2026 07:00:00 GMT
 coherus oncology q4 2025 earnings call transcript  MarketBeat Mon, 09 Mar 2026 07:00:00 GMT
 coherus biosciences (chrs) q4 earnings preview: what to expect  GuruFocus Sun, 08 Mar 2026 08:00:00 GMT
 coherus biosciences's earnings outlook  Sahm Fri, 06 Mar 2026 08:00:00 GMT
 coherus biosciences at td cowen conference: strategic oncology shift  Investing.com Nigeria Thu, 05 Mar 2026 03:52:41 GMT
 coherus biosciences at td cowen conference: strategic oncology shift  Investing.com Wed, 04 Mar 2026 08:00:00 GMT
 published on: 2026-03-01 11:10:06  baoquankhu1.vn Sun, 01 Mar 2026 04:13:46 GMT
 published on: 2026-02-28 11:24:15  baoquankhu1.vn Fri, 27 Feb 2026 16:26:12 GMT
 published on: 2026-02-27 23:23:28  baoquankhu1.vn Fri, 27 Feb 2026 16:26:12 GMT
 10th circ. backs pharmaceutical co. in vaccine policy suit  Law360 Thu, 26 Feb 2026 00:47:00 GMT
 Coherus investor talks stream online from Boston and Miami  Stock Titan Mon, 23 Feb 2026 08:00:00 GMT
 the oncology institute appoints kim tzoumakas to board  Investing.com Mon, 23 Feb 2026 08:00:00 GMT
 coherus oncology to participate in upcoming investor conferences  marketscreener.com Mon, 23 Feb 2026 08:00:00 GMT
 coherus closes $50.1 million public offering of common stock  Investing.com Australia Wed, 18 Feb 2026 08:00:00 GMT
 coherus closes $50.1 million public offering of common stock  Investing.com Tue, 17 Feb 2026 08:00:00 GMT
 coherus biosciences completes $47 million equity offering  TipRanks Tue, 17 Feb 2026 08:00:00 GMT
 published on: 2026-02-17 11:38:22  baoquankhu1.vn Tue, 17 Feb 2026 04:38:54 GMT
 published on: 2026-02-17 11:38:22  baoquankhu1.vn Mon, 16 Feb 2026 22:38:54 GMT
 published on: 2026-02-14 23:45:09  mfd.ru Sat, 14 Feb 2026 20:46:56 GMT
 chrs successfully completes joint book-running offering  GuruFocus Sat, 14 Feb 2026 02:34:56 GMT
 coherus oncology prices stock offering to raise $50.1m  MSN Sat, 14 Feb 2026 00:17:38 GMT
 chrs successfully completes joint book-running offering  GuruFocus Fri, 13 Feb 2026 12:52:37 GMT
 coherus oncology prices stock offering to raise $50.1m  MSN Fri, 13 Feb 2026 11:20:24 GMT
 coherus biosciences (chrs) announces public stock offering  GuruFocus Fri, 13 Feb 2026 08:15:00 GMT
 coherus oncology prices $50.1 million public offering of common stock  Investing.com Fri, 13 Feb 2026 08:00:00 GMT

Coherus BioSciences, Inc
(NASDAQ:CHRS) 

CHRS stock logo

Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its product candidate pipeline...

Founded: 2010
Full Time Employees: 306
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends